Dean J. Mitchell - Insider Trading & Ownership

Entity
Individual
Location
C/O Bristol Myers Squibb Co, 345 Park Ave, New York, NY
Summary
The estimated net worth of Dean J. Mitchell is at least $1.54M dollars as of June 6, 2024. Dean J. Mitchell is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $845K. Dean J. Mitchell is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $696K.
All Insider Reports
All Insider Reports

Ownership of Dean J. Mitchell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PGEN PRECIGEN, INC. Director $845K Mar 14, 2024
TBPH Theravance Biopharma, Inc. Director $696K May 8, 2024
IMGN ImmunoGen, Inc. Director $0 Feb 12, 2024
KNTE Kinnate Biopharma Inc. Director Apr 3, 2024
PRAX Praxis Precision Medicines, Inc. Director Jun 5, 2024

Insider Transactions Reported by Dean J. Mitchell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.